Oct 12 (Reuters) - Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.



Latest News

CBS: How children move through the U.S. immigration system

ABC: Mandy Moore's retro-style home is gorgeous and we all want to live there

ABC: Alone with walls of 'Bagel' and 'Biscuit,' Paul Manafort ponders his defense

USA Today: Search for this neckline increases thanks to Duchess Meghan

USA Today: Kupchak: Kemba Walker focal point of franchise going forward

USA Today: Harvick, Busch, NASCAR's dominating drivers could help others in playoffs

USA Today: Take 2: Sexton to wear Irving's jersey number with Cavaliers

USA Today: Drivers endorse NASCAR's decision to delay use of All-Star Race package

Daily Mail: Uber driver charged with pointing gun at texting motorist

Daily Mail: Xhaka and Shaqiri score for Swiss, make Albanian symbol

CNBC: Trump autographed photos of deceased crime victims for White House 'Angel Families' event

CTV News: Woman drowns in Pukatawagan Lake

CTV News: Leamington firefighters discover woman’s body after house fire

CTV News: Severe thunderstorm warning issued for part of northern Alberta

CTV News: TSX hits record high as New York markets mixed; Canadian dollar up

Reuters: Firefighters tackle large blaze near London's Euston train station

Reuters: Dow snaps losing streak on energy lift

Reuters: Dow snaps losing streak on energy lift

WashingtonPost: How Southwest border apprehensions this year compare with those in earlier years

WashingtonPost: Can freedom survive the Internet?

NewYorkTimes: 18 Tweets on What It’s Like to Tour a Children’s Detention Center

NewYorkTimes: Trump, Defending Immigration Policy, Laments Deaths Caused by People Who ‘Shouldn’t Be Here’

FOX: Fired for being gay: How it’s legal in 28 states